Duration of Red Blood Cell Storage Prior to Transfusion

March 21, 2018 updated by: Steven L. Spitalnik, Columbia University

Duration of Red Blood Cell Storage Prior to Transfusion and Non-Transferrin-Bound Iron

This study will determine the minimal duration of red blood cell (RBC) storage that leads to increases in circulating non-transferrin-bound iron in healthy human volunteers post-transfusion. The results from this study will help guide national guidelines for appropriate duration of RBC storage prior to transfusion, which is currently 6 weeks by Food and Drug Administration (FDA) criteria. The overall objective of this research is to improve the safety of refrigerated storage of red blood cells before transfusion.

Study Overview

Detailed Description

Recent studies suggest that older stored blood is associated with worse outcomes in certain hospitalized patients. Red cells may be stored in a refrigerator prior to transfusion for up to 42 days by current FDA standards. Refrigerator storage of red cells is associated with a storage lesion and the survival of transfused red cells decreases with increasing storage time, thus older blood is associated with an increased delivery of hemoglobin-iron to certain parts of the body. The investigators have preliminary data in mice and humans suggesting that delivery of a significant iron load from aged red cells leads to the production of a potentially toxic form of circulating iron called non-transferrin-bound iron.

In this prospective study of healthy volunteers, each subject will be randomized to receive transfusion of one RBC unit after 1, 2, 3, 4, 5, or 6 weeks of storage. The primary outcome will be the 24 hr area under the curve (AUC) of the serum non-transferrin bound iron concentration calculated from samples collected at 0, 2, 4, 6, 8, 10, 12, 14 and 24 hours after transfusion.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10032
        • Columbia University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18-65 years old
  • Body weight >110 lbs
  • Hemoglobin >12.5 g/dL

Exclusion Criteria:

  • Ineligible for donation based on the New York Blood Center blood donor questionnaire
  • Systolic blood pressure >180 or <90 mm Hg, diastolic blood pressure >100 or <50 mm Hg
  • Heart rate <50 or >100
  • Temperature >99.5 F prior to donation
  • Temperature >100.4 F or subjective feeling of illness prior to transfusion (this is to avoid having a concurrent illness affect post-transfusion measurements);
  • Positive results on standard blood donor infectious disease testing
  • Positive urine pregnancy test

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Transfusion of PRBC stored for 1 week
Subjects will receive blood transfusion with packed red blood cells stored for 1 week.
A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.
Other Names:
  • Red blood cell (RBC) transfusion

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

  • 1 week
  • 2 weeks
  • 3 weeks
  • 4 weeks
  • 5 weeks
  • 6 weeks
Other Names:
  • PRBC
Experimental: Transfusion of PRBC stored for 2 weeks
Subjects will receive blood transfusion with packed red blood cells stored for 2 weeks.
A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.
Other Names:
  • Red blood cell (RBC) transfusion

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

  • 1 week
  • 2 weeks
  • 3 weeks
  • 4 weeks
  • 5 weeks
  • 6 weeks
Other Names:
  • PRBC
Experimental: Transfusion of PRBC stored for 3 weeks
Subjects will receive blood transfusion with packed red blood cells stored for 3 weeks.
A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.
Other Names:
  • Red blood cell (RBC) transfusion

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

  • 1 week
  • 2 weeks
  • 3 weeks
  • 4 weeks
  • 5 weeks
  • 6 weeks
Other Names:
  • PRBC
Experimental: Transfusion of PRBC stored for 4 weeks
Subjects will receive blood transfusion with packed red blood cells stored for 4 weeks.
A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.
Other Names:
  • Red blood cell (RBC) transfusion

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

  • 1 week
  • 2 weeks
  • 3 weeks
  • 4 weeks
  • 5 weeks
  • 6 weeks
Other Names:
  • PRBC
Experimental: Transfusion of PRBC stored for 5 weeks
Subjects will receive blood transfusion with packed red blood cells stored for 5 weeks.
A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.
Other Names:
  • Red blood cell (RBC) transfusion

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

  • 1 week
  • 2 weeks
  • 3 weeks
  • 4 weeks
  • 5 weeks
  • 6 weeks
Other Names:
  • PRBC
Experimental: Transfusion of PRBC stored for 6 weeks
Subjects will receive blood transfusion with packed red blood cells stored for 6 weeks.
A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.
Other Names:
  • Red blood cell (RBC) transfusion

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

  • 1 week
  • 2 weeks
  • 3 weeks
  • 4 weeks
  • 5 weeks
  • 6 weeks
Other Names:
  • PRBC

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Non-transferrin-bound Iron Level (AUC)
Time Frame: 0, 2, 4, 6, 8, 10, 12, 14 and 24 after transfusion
Area under the curve of change of Non-transferrin-bound iron from immediately after transfusion to end of observation (i.e., from 0-hr after transfusion to 24-hr after transfusion).
0, 2, 4, 6, 8, 10, 12, 14 and 24 after transfusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Steven L Spitalnik, MD, Columbia University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2014

Primary Completion (Actual)

February 1, 2016

Study Completion (Actual)

February 1, 2016

Study Registration Dates

First Submitted

March 12, 2014

First Submitted That Met QC Criteria

March 13, 2014

First Posted (Estimate)

March 14, 2014

Study Record Updates

Last Update Posted (Actual)

April 19, 2018

Last Update Submitted That Met QC Criteria

March 21, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • AAAI0835
  • R01HL115557 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Iron, Blood Level Abnormal

Clinical Trials on Blood Transfusion

3
Subscribe